Mediclin AG
XHAM:MED

Watchlist Manager
Mediclin AG Logo
Mediclin AG
XHAM:MED
Watchlist
Price: 2.86 EUR -2.05% Market Closed
Market Cap: 204.8m EUR

Mediclin AG
Investor Relations

MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 7,115 full-time employees. The company went IPO on 2000-12-04. The firm operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).

Show more
Loading
MED
DAX Index
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

No Earnings Calls Available

Management

Dr. Joachim Ramming
Chairman of Management Board & CEO
No Bio Available
Mr. Tino Fritz
CFO & Member of the Management Board
No Bio Available
Mr. Thomas Piefke
COO & Member of Management Board
No Bio Available
Mr. Mario Waidele
Head of Group Accounting
No Bio Available
Ender Gulcan
Head of Investor Relations and Sustainability
No Bio Available
Ms. Katja Kiesewetter
Head of Law
No Bio Available
Mr. Jörg Störmer
Head of Purchasing & Medical Technology
No Bio Available
Ms. Carin Emminghaus
Head of Payroll & Application Management
No Bio Available
Dr. Ralf Bürgy
Head of Quality Medicine & Head of Internal Auditing
No Bio Available
Mr. Frank Heuberger
Head of Finance & Accounting
No Bio Available

Contacts

Address
BADEN-WUERTTEMBERG
Offenburg
Okenstr. 27
Contacts
+497814880.0
www.mediclin.de
sparklesyt

See Also

Summary
MED intrinsic value, competitors valuation, and company profile.
DCF Valuation
MED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MED stock valuation using valuation multiples.
Wall Street Estimates
MED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.